Building Competence. Crossing Borders.

CAS Swiss Biodesign for MedTech Innovators August – November 2020

In Cooperation with Prof. Tom Krummel of Stanford University’s Byers Center for Biodesign

Building Competence. Crossing Borders.

For more information contact:www.zhaw.ch/imm/casswissbiodesign or

E-Mail: biodesign.sml@zhaw.ch

Key Guest Faculty

Academic Faculty

Fast Facts ‘CAS Swiss Biodesign for MedTech Innovators’Switzerland’s first, medical technology-specialized product innovation program

Course Dates and Location 2020

16 days incl. 4 Saturdays (half-days) / 12 ECTS• Aug 18-22, Sep 9-12, Oct 9-12, Nov 5-7• Plus remote time for pre-readings and project work• Location: Kick-off hotel, ZHAW campus, Balgrist and

KSW hospital in Winterthur & Zurich

Course Fees

• CHF 11’800 for self-paying participants• Early-bird reduction for applications by March 1st

• Corporate package available upon request• Incl. tuition fees, expert coaching, service lab,

first week in kick-off hotel and course material

Goals

Learn to identify major market opportunities throughreal-life clinical immersion and the Biodesign process.Get serial-innovator coaching to invent high potential,patentable products and prepare compelling businesscases.

Prof. Tom Krummel, MDCo-Director, Stanford UniversityByers Center for Biodesign

Swiss Biodesign Alumni 2019

1. Stanford’s pioneering Biodesign Concept

2. Swiss Biodesign Mission

3. Target Group

4. Project Teams

5. Curriculum

6. Faculty

7. Participants’ Benefits

8. Application Process

9. Testimonials

10.Contact

Agenda

3

1. Stanford Biodesign Concept – Why pioneering?Medtech-specialized, interdisciplinary, hands-on training and coaching

4

Key Features• A full-time fellowship with

Design thinking at the core

• 12 hand-selected fellows in interdisciplinary teams

• Fundamentals of disease, regulatory, reimbursement, IP, business strategy

• Clinical immersion in hospitalincluding shadowing ofphysicians and patients

• Faculty of the US’ most renowned medtech serial-innovators and specialists

1. Stanford Biodesign – Global ImpactThe most effective health technology training concept worldwide

900+Patents, abstracts, manuscripts, books

$700 MioCapital raised from grants and venture

capitalists

1.5 MioPatients treated with

devices from the training program

50+Startups created by course alumni

200+Fellows trained full-time to innovate in corporations, hospitals and start-ups

18Biodesign-based

programs from Tokyo to Oxford to Zurich

1. Stanford Biodesign – Impact of 16 x 12 Biodesign Alumni50% continue inventing in corporations, 50% create start-ups such as…

Lymph/Axis

BRÜN

So Far…

Market Success of Biodesign Alumni:

• Shockwave Medical / intravascular litho-tripsy therapy: IPO (2019), raised $97 million

• iRythm Technologies / wearable heartmonitoring: IPO (2016), raised $107 million

• Oculeve / dry eye disease: Acquired (2015) by Allergan for $125 million

I. We want to provide our Biodesign participants with the skills, networkand experience to identify major market opportunities and invent highpotential medical and health technology: Products, or services thatsignificantly improve current standards of care for patients and practionners.

II. We want to drive cultural change within local medical device-, in-vitro-and mobile diagnostic companies by promoting a needs-focused versustechnology-focused innovation culture.

III.We want to achieve this through Switzerland’s most effective and market-oriented training program for healthcare intra- and entrepreneurs.

2. Swiss Biodesign – Our Mission

7

3. CAS Swiss Biodesign – Target GroupLimited to 12 Healthcare professionals / researchers

8

Target GroupThis program is designed for restless, results- and team-orientedindividuals motivated to tackle major healthcare problems. To bewell-equipped for this endeavor, candidates should have at leastthree years of professional healthcare experience in a technical,clinical, or business function and a proven track record of havingadvanced innovative projects.

Formal Requirements• Master’s, MD or PhD degree (engineering, IT, medicine, life

sciences, business, design, or law preferred)• Very good oral and written English (equivalent to CEFR level C1)• Applications are welcome from any country (as long as meeting

Swiss VISA requirements)• A max. of two persons will be accepted from the same company

Clinical BusinessTechnical

e.g. Sr. R&D Engineer /Software Developer / ….

4. CAS Swiss Biodesign – Project TeamsParticipants will work in small, interdisciplinary groups on a real-life product project

e.g. Sales Reps / ProductManager / BusDev. Mgr / …

e.g. Consultant Gynecology / Cardiologist / exp. OR Nurse /...

+ +

Clinical ImmersionOver several days of clinical immersion at partner hospitals, you will join surgeries, shadowpatients/physicians/nurses, learn to spot unfulfilled needs and conduct effective interviews.Primary access to physicians and clinical departments will be organized.

Project TeamsAt the first day of the course, interdisciplinary project teams with three to four members will beformed. Your task will be to explore real-life customer needs in a new medical field and graduallydevelop one of them to a promising, customer-validated business case and patentable productconcept.

5. CAS Swiss Biodesign – CurriculumFour intense modules over 3 months in and around Zurich

10

Module 1a) Clinical Needs & Market Research

4.5 Days

• Biodesign process• Team formation and

strategy• Needs finding• Disease

fundamentals• Market research• Clinical immersion I• Group coaching &

presentations

Module 1b) Clinical Needs & Idea Generation

3.5 Days

• Clinical immersion II• Design thinking• Concept

development & prototyping

• Regulatory & Clinical strategy

• Patent search• Group coaching &

presentations

Module 2a) Product and

Business Concept3.5 Days

• Business model andcase preparation

• Reimbursementsystems

• Health economics• Market access• Group coaching &

presentations

Evening group work / tele-coachings / insider talksBetween modules: Approx. 15-20 hours of project work

Pre-Reading & Online-Test

Module 2b) Entrepreneurship

2.5 Days

• MedTech start-upsuccess factors

• Start-up teamcreation & funding

• Company visits• Final presentation:

‘Product concept & business pitch’

• Graduation dinner

5. CAS Swiss Biodesign – Module 1aWith impressions from Swiss Biodesign Bootcamp 2019

11

Evening group work / coachings / insider talks

Module 1a) Clinical Needs & Market Research

4.5 Days

• Biodesign process• Team formation and

strategy• Needs finding• Disease

fundamentals• Market research• Clinical immersion I• Group coaching &

presentations

5. CAS Swiss Biodesign – Module 1bWith impressions from Swiss Biodesign Bootcamp 2019

12

Evening group work / coachings / insider talks

Module 1b) Clinical Needs & Idea Generation

3.5 Days

• Clinical immersion II• Design thinking• Concept

development & prototyping

• Regulatory & Clinical strategy

• Patent search• Group coaching &

presentations

5. CAS Swiss Biodesign – Module 2aWith impressions from Swiss Biodesign Bootcamp 2019

13

Evening group work / coachings / insider talks

Module 2a) Product and

Business Concept3.5 Days

• Business model andcase preparation

• Reimbursementsystems

• Health economics• Market access• Group coaching &

presentations

5. CAS Swiss Biodesign – Module 2b (Final)With impressions from Swiss Biodesign Bootcamp 2019

14

Evening group work / coachings / insider talks

Module 2b) Entrepreneurship

2.5 Days

• MedTech start-upsuccess factors

• Start-up teamcreation & funding

• Company visits• Final presentation:

‘Product concept & business pitch’

• Graduation dinner

6. CAS Swiss Biodesign – FacultyInnovation experience from leading healthtech start-ups, corporations & hospitals

15

Tom Krummel, MDProf., Co-Director

Stanford Biodesign

Jens Haarmann, PhD, Program Director Swiss

Biodesign, ZHAW

Patrick Griss, PhD, Executive

Partner, Zühlke

Laurent Grandidier,MBA, Serial

Entrepreneur

Orestis Vardoulis, PhD, Stanford

Biodesign Alumni

Mathias Bonmarin, Prof., Computa-tional Physics

ZHAW

Heiko Visarius, PhD, Startup

Coach & Founder Visartis

Philippe Etter, Msc, Senior

Partner, Medidée

Michel Adamina, MD, Prof., Chief Physician, KS

Winterthur

Christian Mühlendyck, MD, MBA, Dir. HE&MA, J&J

Markus Ott, Msc, Head Global

Market Access, Roche

Philipp Tholen, Msc, Co-Founder

VP Product,AvaWomen

Jess Snedeker,Prof. Orthopedic Biomechanics,

ETH Zurich

Rainer Fuchs,Prof., Head Product

Mgt Center, ZHAW

7. CAS Swiss Biodesign – Benefits for ParticipantsSkills and career enhancing

16

Skills Career

1. Learn to systematically identify andinvent high potential product ideas

2. Know how to use the tools to objectively assess the market potential

3. Understand the ingredients for a compelling business case

4. Learn from serial-innovators about common pitfalls in navigating high-risk health technology projects

1. Plan future projects with indepth under-standing of Biodesign tools

2. Gain experience and confidence to successfully lead high-risk innovation projects and drive organisational change

3. Collect 12 ECTS credit points for future academic programs

4. Join a unique medical technology networkin Europe and the US

Application documents• One page motivational letter, CV and latest diplomas• Two reference letters from supervisors / project partners• In English and in PDF format

Application process• Please email your complete application by May 11th, 2020 the

latest to biodesign.sml@zhaw.ch• A CHF 1’000 fee reduction is applicable, if your early-bird

application is handed in by March 1st, 2020• For selected candidates, an interview with two faculty mem-

bers will be arranged between March and June (personal or video depending on distance)

• Contact us for more information on up to three scholarships for PhD researchers and young physicians

8. CAS Swiss Biodesign – Application ProcessEarly-bird application deadline of March 1st, 2020

17

9. Testimonials

«The Swiss Biodesign Bootcamp has taught me invaluable tools aroundproduct innovation that I will continue to use in everyday life. I now have adifferent way of thinking and have met incredible people along the journey.»

Pryanka Chadha, MEng, Technology Risk Analyst, PWC London

18

Alumni of Swiss Biodesign 2019

«At the end of the Swiss Biodesign bootcamp, we already filed our first patentand gained a network of amazing experts all around the world.»Andrea Aegerter, Msc, PhD Candidate, ZHAW Health Sciences & Univ. of Zurich

«The course was incredible: An amazing quality of speakers from thebeginning to the end and the hands-on experience to run through the wholeprocess of innovation. As far as I know, a one of its kind in this part ofEurope.»

Jonathan Douissard, MD, Staff Surgeon, University Hospital Geneva

9. Testimonials

19

Alumni of Swiss Biodesign 2019

«The Biodesign program is a practical and effective way to understand anunmet clinical need, find a solution and what is needed to bring it to thepatient.»Saeid Kasiri, PhD, New Product Dev. Project Manager, Straub Medical, Wangs

«A real bootcamp to come up with a major innovation: Top guest lecturerswith a lot of experience will coach you through important steps. And a greatopportunity to build your network in the medtech field and meet greatpeople.»Lea Dal Fabbro, Msc, PhD Candidate, ZHAW Biomechanical Eng., Winterthur

«My personal highlight of the past five years. The course provides the missingpiece on how to come to a real need-based business case and provideseverything to go one step further.»

Christian Frei, Master Audiologist, Senior Custom Project Leader, Sonova, Stäfa

ZHAW Zurich University of Applied SciencesSchool of Management and LawInstitute for Marketing ManagementTheaterstrasse 17CH-8400 Winterthurwww.zhaw.ch/imm

10. Join us

Jens Haarmann, PhDProgram Director CAS Swiss BiodesignSenior Lecturer Product ManagementE-Mail: jens.haarmann@zhaw.ch or

biodesign.sml@zhaw.chTel.: +41 58 934 61 52

Please contact us for any questions, or to arrange a personal consultation on the CAS Swiss Biodesign:

21 V0701

‘Innovation is 1% inspirationand 99% perspiration.’

Prof. Tom Krummel, MD Stanford University